Finance

Lists
IC7:FRA
ICU Medical Inc
€162.00
0.00%
(0.00) 1D
Nov 10, 9:55:02 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IC7...
Mkt. cap
4.55B
Avg. vol.
0.00
Volume
0.00
52-wk high
€161.00
52-wk low
€97.00
No. of employees
13K
Mkt. cap
4.55B
Avg. vol.
0.00
Volume
0.00
52-wk high
€161.00
52-wk low
€97.00
No. of employees
13K
News stories
From web sources and news partners
Profile
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
About ICU Medical Inc
CEOVivek Jain
Employees13K
Founded1984
HeadquartersSan Clemente, California, United States
SectorHealth Care
IndustryMedical device
Websiteicumed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
540.70M
530.22M
551.68M
560.44M
Cost of goods sold
337.72M
324.00M
335.53M
325.68M
Cost of revenue
337.72M
324.00M
335.53M
325.68M
Research and development expenses
21.09M
21.28M
22.70M
21.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155.81M
154.57M
151.92M
154.41M
Operating expense
176.90M
175.85M
174.62M
176.16M
Total operating expenses
514.62M
499.84M
510.15M
501.85M
Operating income
26.09M
30.38M
41.53M
58.59M
Other non operating income
-32.00K
-17.00K
1.18M
-3.14M
EBT including unusual items
-18.39M
-4.58M
26.16M
34.04M
EBT excluding unusual items
4.75M
12.35M
29.13M
38.07M
Income tax expense
-2.65M
-34.71M
7.07M
7.19M
Effective tax rate
14.43%
757.62%
27.03%
21.13%
Other operating expenses
-
-
-
-
Net income
-15.73M
30.13M
19.09M
26.85M
Net profit margin
-2.91%
5.68%
3.46%
4.79%
Earnings per share
1.91
1.97
2.37
2.44
Interest and investment income
2.14M
2.04M
2.81M
-
Interest expense
-22.78M
-18.53M
-18.56M
-15.24M
Net interest expenses
-20.64M
-16.49M
-15.75M
-15.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
76.92M
80.41M
91.14M
108.19M
Gain or loss from assets sale
2.69M
136.00K
1.85M
-2.15M
Upcoming events
AI content may include mistakes. Learn more
Google apps